Why Broadcom Stock Is Still Going Down

Broadcom beat Q2 2026 earnings with pro forma EPS of $2.44 and GAAP EPS of $1.91, while raising Q3 revenue guidance to $29.4B, up 32% sequentially and 89% year over year. Investor concern centered on AI revenue guidance of $16B versus the $17.2B Wall Street expected, even though overall growth and margins remain strong. The stock fell 12.6% after the report and was down another 4.2% in Friday morning trading.

Analysis

The market’s reaction says less about the quarter and more about the setup: AVGO is now priced like a quasi-infrastructure AI compounder, so any shortfall versus the most aggressive AI buildout assumptions becomes a de-rating event. The key second-order issue is that AI revenue concentration is creating a higher-duration equity story while the rest of the business is increasingly ignored; that makes the stock more sensitive to tiny changes in customer capex pacing and hyperscaler digestion cycles than to absolute growth. In other words, the move is about expectation gravity, not just fundamentals.

The broader read-through is mixed for NVDA and the semiconductor supply chain. If one of the largest beneficiaries of AI capex can miss on the AI component of guidance while still delivering strong consolidated growth, the market may start scrutinizing “AI revenue quality” across the group, pressuring names that rely on forward order visibility and premium multiples. That said, this is not a demand-collapse signal; it is a positioning reset that can compress multiple expansion across the AI basket for several weeks if the next catalyst set is weak.

The contrarian view is that the selloff may be overdone relative to cash flow durability. Stable high margins plus very large top-line growth imply the fundamental floor is still rising, and the stock is now discounting a much more severe slowdown than the data justify. The risk to being too bearish is that management has repeatedly shown an ability to re-accelerate guidance after digestion periods, so a 1-2 quarter horizon matters more than one print. If AI spend merely normalizes rather than stalls, the current drawdown could reverse quickly.

Key Decisions for Investors

• Sell near-dated AVGO downside into elevated post-earnings volatility; use a 2-6 week horizon because the stock is likely to mean-revert if the market stops treating a modest AI guide miss as a regime change.
• Pair trade: long NVDA / short AVGO for 1-3 months if you expect the market to favor the cleaner AI pure-play narrative over a diversified compounder with higher expectations. Risk: if AVGO stabilizes and catalysts remain scarce, the pair can chop.
• Add AVGO only on further weakness toward a more defensible valuation band; size it as a long-duration compounder, not a momentum trade. Risk/reward improves if the name de-risks another 5-10% without evidence of a customer spend cut.
• Reduce beta exposure across the AI basket for 1-4 weeks via index or semiconductor hedges; the immediate risk is multiple compression, not earnings revision. This is a sentiment hedge, not a thesis hedge.
• For traders willing to express a rebound, buy AVGO call spreads 1-2 months out after volatility settles; the setup favors a snapback if management commentary or follow-through buying restores confidence in AI demand durability.